A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novo Nordisk A/S
Related studies linked through entity extraction aliases.
Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
- Status
- WITHDRAWN
- Phase
- N/A
A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 Diabetes
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Impact of Liraglutide 3.0 on Body Fat Distribution
- Status
- COMPLETED
- Phase
- PHASE4
Saxenda in Obesity Services (STRIVE Study)
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin
- Status
- COMPLETED
- Phase
- PHASE3
Dose-response, Safety and Efficacy of Oral Semaglutide Versus Placebo and Versus Liraglutide, All as Monotherapy in Japanese Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy of Oral Semaglutide Versus Dulaglutide Both in Combination With One OAD (Oral Antidiabetic Drug) in Japanese Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity
- Status
- COMPLETED
- Phase
- PHASE1
A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A
- Status
- COMPLETED
- Phase
- PHASE1
Transformative Research in Diabetic Nephropathy
- Status
- RECRUITING
- Phase
- N/A
Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes
- Status
- COMPLETED
- Phase
- NA
Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
- Status
- COMPLETED
- Phase
- PHASE2
In-market Utilisation of Liraglutide Used for Weight Management in Europe
- Status
- COMPLETED
- Phase
- N/A
Long Term Survivors of High-grade Glioma and Their Caregivers
- Status
- COMPLETED
- Phase
- N/A
LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
- Status
- COMPLETED
- Phase
- PHASE3
A Trial Investigating the Safety, Tolerability, Pharmacokinetics (the Exposure of the Trial Drug in the Body) and Pharmacodynamics (the Effect of the Investigated Drug on the Body) of Insulin 287 in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE1